Driving Clinical Data Transformation Through Strategic Sponsor and CRO Collaboration

For sponsors and contract research organizations (CROs), trial complexity is increasing due to novel protocol requirements and greater demands on data volume and variety, among other factors. Meanwhile, the research and development product pipeline doubled from 2013 to 2023. Sponsors are increasingly leaning on CRO expertise for newer therapeutic areas, technology infrastructure, evolving regulatory expertise, change management, and more.

CRA Turnover Within Contract Research Organizations Post-COVID-19: A Cross-Sectional Study

This article presents findings from a survey that was designed to investigate the factors contributing to turnover intentions among clinical research associates (CRAs) within contract research organizations. Previous studies suggest factors associated with high turnover among CRAs include financial compensation, workload, career development, and management, yet little data are available regarding factors influencing turnover post-COVID-19.